These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30931907)

  • 1. [Pathological consequences of excess of interferon in vivo].
    Lebon P; Crow YJ; Casanova JL; Gresser I
    Med Sci (Paris); 2019 Mar; 35(3):232-235. PubMed ID: 30931907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-viral treatment: pro or cons type I IFN?].
    Whitehead P; Drouet B; Zagury D; Bensussan A
    Med Sci (Paris); 2013 Oct; 29(10):836-9. PubMed ID: 24148119
    [No Abstract]   [Full Text] [Related]  

  • 3. Interferon alpha-induced lupus: proof of principle.
    Niewold TB
    J Clin Rheumatol; 2008 Jun; 14(3):131-2. PubMed ID: 18525429
    [No Abstract]   [Full Text] [Related]  

  • 4. Type-I interferons and systemic lupus erythematosus.
    Koutouzov S; Mathian A; Dalloul A
    Autoimmun Rev; 2006 Oct; 5(8):554-62. PubMed ID: 17027892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferon and autoimmune disease.
    Crow MK
    Autoimmunity; 2003 Dec; 36(8):445-6. PubMed ID: 14984020
    [No Abstract]   [Full Text] [Related]  

  • 6. A Brief Historical Perspective on the Pathological Consequences of Excessive Type I Interferon Exposure In vivo.
    Crow YJ; Lebon P; Casanova JL; Gresser I
    J Clin Immunol; 2018 Aug; 38(6):694-698. PubMed ID: 30187308
    [No Abstract]   [Full Text] [Related]  

  • 7. Type I interferon in systemic lupus erythematosus and other autoimmune diseases.
    Banchereau J; Pascual V
    Immunity; 2006 Sep; 25(3):383-92. PubMed ID: 16979570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genetics of type I interferon in systemic lupus erythematosus.
    Bronson PG; Chaivorapol C; Ortmann W; Behrens TW; Graham RR
    Curr Opin Immunol; 2012 Oct; 24(5):530-7. PubMed ID: 22889593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overview of the biology of type I interferons.
    Kalliolias GD; Ivashkiv LB
    Arthritis Res Ther; 2010; 12 Suppl 1(Suppl 1):S1. PubMed ID: 20392288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferons: the pathways of discovery. II. Immunomodulatory, in vivo and applied aspects.
    Billiau A
    J Clin Virol; 2007 Aug; 39(4):241-65. PubMed ID: 17580123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lupus erythematosus and Sjögren's syndrome induced in a case by interferon-alpha used for the treatment of hepatitis C.
    Onishi S; Nagashima T; Kimura H; Matsuyama Y; Yoshio T; Minota S
    Lupus; 2010 May; 19(6):753-5. PubMed ID: 20064909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.
    López de Padilla CM; Niewold TB
    Gene; 2016 Jan; 576(1 Pt 1):14-21. PubMed ID: 26410416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in cytokines in cutaneous and systemic lupus erythematosus.
    Mikita N; Ikeda T; Ishiguro M; Furukawa F
    J Dermatol; 2011 Sep; 38(9):839-49. PubMed ID: 21767292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic lupus erythematosus following virological response to peginterferon alfa-2b in a transplanted patient with chronic hepatitis C recurrence.
    Lodato F; Tame MR; Colecchia A; Racchini C; Azzaroli F; D'Errico A; Casanova S; Pinna A; Roda E; Mazzella G
    World J Gastroenterol; 2006 Jul; 12(26):4253-5. PubMed ID: 16830387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental approach to the pathogenesis of systemic lupus erythematosus].
    Lambert PH; Creighton D; Goodman R; Bankhurst A; Mischer PA
    J Urol Nephrol (Paris); 1972 Dec; 78(12):973-80. PubMed ID: 4350279
    [No Abstract]   [Full Text] [Related]  

  • 16. The type I interferon system in systemic lupus erythematosus.
    Rönnblom L; Eloranta ML; Alm GV
    Arthritis Rheum; 2006 Feb; 54(2):408-20. PubMed ID: 16447217
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunoregulatory disturbances in human and murine systemic lupus erythematosus.
    Santoro TJ
    Clin Exp Rheumatol; 1986; 4(2):169-74. PubMed ID: 2426025
    [No Abstract]   [Full Text] [Related]  

  • 18. Interferon regulatory factors: beyond the antiviral response and their link to the development of autoimmune pathology.
    Santana-de Anda K; Gómez-Martín D; Díaz-Zamudio M; Alcocer-Varela J
    Autoimmun Rev; 2011 Dec; 11(2):98-103. PubMed ID: 21872684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon and 2-5A synthetase in patients with immune diseases.
    Preble OT; Yeh TJ; Silverman RH; Klippel JH; Straus SE; Gelmann EP
    Prog Clin Biol Res; 1985; 202():415-22. PubMed ID: 2421319
    [No Abstract]   [Full Text] [Related]  

  • 20. A timely review series on SLE: Why it is needed and paving the way forward.
    Fairhurst AM
    Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i1-i2. PubMed ID: 28064211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.